Haemonetics Corp. | Balance Sheet

Fiscal year is April-March. All values USD Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
192
161
115
140
180
169
Total Accounts Receivable
165
146
157
153
151
185
Inventories
198
211
187
177
161
194
Other Current Assets
68
53
29
41
29
27
Total Current Assets
623
570
488
510
521
576
Net Property, Plant & Equipment
271
322
338
324
332
344
Intangible Assets
608
579
472
388
368
339
Other Assets
11
11
14
12
12
12
Total Assets
1,514
1,485
1,319
1,239
1,237
1,275
ST Debt & Current Portion LT Debt
46
22
43
61
194
Accounts Payable
54
48
40
43
55
Income Tax Payable
3
4
-
4
5
Other Current Liabilities
115
115
102
103
130
Total Current Liabilities
217
189
186
211
385
Long-Term Debt
392
406
365
254
59
Provision for Risks & Charges
-
-
20
16
25
Deferred Taxes
28
29
14
8
3
Other Liabilities
38
32
6
6
10
Total Liabilities
676
659
598
499
485
Common Equity (Total)
838
826
722
740
752
Total Shareholders' Equity
838
826
722
740
752
Total Equity
838
826
722
740
752
Liabilities & Shareholders' Equity
1,514
1,485
1,319
1,239
1,237

About Haemonetics

View Profile
Address
400 Wood Road
Braintree Massachusetts 02184
United States
Employees -
Website http://www.haemonetics.com
Updated 07/08/2019
Haemonetics Corp. is a healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software.